Tag: Impella CP

ADVERTORIAL: Further data underline the critical role of Impella Heart Pumps...

Findings from an interim analysis of PROTECT III have added to the evidence for improved outcomes with Impella heart pumps in protected percutaneous coronary...

ESC 2019: Abiomed launches Impella SmartAssist platform

At the 2019 European Society Cardiology (ESC) congress (31 August – 4 September, Paris, France), Abiomed revealed that its Impella CP with SmartAssist technology is...

AHA 2018: Pilot study paves way for future evaluation of delaying...

A pilot study comparing a strategy of left ventricular unloading with the Impella CP device (Abiomed) and delayed reperfusion (up to 30 minutes after...

TCT 2018: Use of Impella in cardiogenic shock patients associated with...

A new analysis of data from the Impella (Abiomed) Quality (IQ) Database shows a relative increase of 24% in mean survival in acute myocardial...

Abiomed receives FDA approval for Impella CP with SmartAssist and Optical...

Abiomed has received US FDA premarket approval (PMA) for its Impella CP heart pump with SmartAssist, using an optical sensor. At the forefront of innovation, according...

Abiomed introduces third generation Impella CP heart pumps at SCAI 2017

Abiomed has announced the debut of the third generation Impella CP heart pump at the Annual meeting of the Society for Cardiovascular and Angiography...